Stock Update: Eli Lilly & Company (NYSE:LLY) – Diversity of Lilly’s Alzheimer’s Disease Pipeline Showcased at the Alzheimer’s Association International Conference® 2016 (AAIC® 2016)

[PR Newswire] – INDIANAPOLIS, July 21, 2016 /PRNewswire/ — Eli Lilly and Company ( NYSE:LLY ) today announced it will present findings from more than 25 research studies at the upcoming Alzheimer’s Association International … Read more on this. , valued at $recting to http://finance.ya, ended session yesterday at $. During the trading session, LLY traded between $ and has traded between $ over the past 12 months. Lilly (LLY) shares are currently priced at x this year’s forecasted earnings, which makes them relatively inexpensive compared to the industry’s x earnings multiple for the same period. According to a consensus of 0 analysts, the earnings estimate of $ per share would be $0.00 worse than the year-ago quarter and a $0.00 sequential decrease. The full-year EPS estimate is $ which would be a $0.00 setback than last year’s full-year earnings. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $0.00 . If realized, that would be a 0.00% decrease over the year-ago quarter. More recently, d LLY from to (/fi). Previously, d LLY from to . Given all the information above, we should disclose to readers that the average price target is $, which is 0.00% below than it opened this morning. See more in (NYSE:LLY) Similar Articles: Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly Declares Third-Quarter 2016 Dividend Market Update: Eli Lilly & Company (NYSE:LLY) – Eli Lilly and Company and AstraZeneca Announce Continuation of Pivotal Clinical Trial for People with Early Alzheimer’s Disease Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly To Present At Leerink Partners Global Healthcare Conference